Capecitabine in pretreated metastatic cholangiocarcinoma. A case report and review of the literature

Journal of B.U.ON.

Volumn 12, Issue 2, 2007, Pages 281-283

  Koutras, A K ^a   Talampuka, G ^a   Pagoni, N ^b   Thomopoulos, K C ^b   Kalliolias, G ^a   Kalogeropoulou, C ^a   Kalofonos, H P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Capecitabine; Cholangiocarcinoma; Metastic pretreated

Indexed keywords

CAPECITABINE; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; GEMCITABINE; OXALIPLATIN; PACLITAXEL;

ADENOCARCINOMA; ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CASE REPORT; CHOLANGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOSCOPIC SURGERY; FATALITY; HUMAN; JAUNDICE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; STENT; TREATMENT DURATION;

ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CHOLANGIOCARCINOMA; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED;

EID: 34447135116     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fong Y, Kemeny N, Lawrence TS. Cancer of the liver and biliary tree. In: DeVita VT Jr, Hellman S, Rosenberg SA (Eds): Cancer. Principles and Practice of Oncology (6th edn). Philadelphia, PA: Lippincott Williams & Wilkins 2001, pp 1162-1203.
2. Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998; 34: 977-986.
3. Glimelius B, Hoffman K, Sjoden PO. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7: 593-600.
4. Davis HL Jr, Ramirez G, Ansfield FJ. Adenocarcinomas of stomach, pancreas, liver, and biliary tract. Survival of 328 patients treated with fluoropyrimidine therapy. Cancer 1974; 33: 193-197.
5. Falkson G, MacIntyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gall bladder and bile duct cancer. Cancer 1984; 54: 965-969.
6. Gebbia V, Giuliani F, Maiello E et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 2001; 19: 4089-4091.
7. Knox JJ, Hedley D, Oza A et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 2005; 23: 2332-2338.
8. Komek GV, Schuell B, Laengle F et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: A randomized phase II tril. Ann Oncol 2004; 15: 478-483.
9. Kim TW, Chang HM, Kang HJ et al. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer. Ann Oncol 2003; 14: 1115-1120.
10. Patt YZ, Hassan MM, Aguayo A et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 2004; 101: 578-586.
11. Stemmler J, Heinemann V, Schalhom A. Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases. Onkologie 2002; 25: 182-184.